Friday, January 10, 2020 12:58:44 PM
BB i was just thinking ANI is going hyper aggressive after new acquisitions
expansion in new factory CA and host of substantial list of new drugs potential launch in 2020 like Corti and late new drug launches on 2019 that we have not seen actual sales yet
IMO Its impossible to process what 2020 guidance will / can be , I assume ANI is sitting on a PPS # that also has "IF FACTOR" yet can assess a level of probability what "IS" going to be approved
One thing that does stand out is they are NOT stopping acquiring new drugs , It s poss it speaks to a partnership and def confidence in manufacturing capabilities , There is steam behind this and IMO lots of unknowns today !
One other observation is PPS 55-58 we lost some of the new posters,
So my answer to your question in all Ernest is 2020 expect "GROWTH" we know this is a very aggressive Co with unrealized value ! GLTA JMHO
expansion in new factory CA and host of substantial list of new drugs potential launch in 2020 like Corti and late new drug launches on 2019 that we have not seen actual sales yet
IMO Its impossible to process what 2020 guidance will / can be , I assume ANI is sitting on a PPS # that also has "IF FACTOR" yet can assess a level of probability what "IS" going to be approved
One thing that does stand out is they are NOT stopping acquiring new drugs , It s poss it speaks to a partnership and def confidence in manufacturing capabilities , There is steam behind this and IMO lots of unknowns today !
One other observation is PPS 55-58 we lost some of the new posters,
So my answer to your question in all Ernest is 2020 expect "GROWTH" we know this is a very aggressive Co with unrealized value ! GLTA JMHO
Recent ANIP News
- ANI Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference • GlobeNewswire Inc. • 05/27/2026 10:50:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/21/2026 08:13:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2026 08:16:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2026 08:15:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2026 08:15:29 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/13/2026 03:04:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2026 12:27:46 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/11/2026 10:34:52 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/11/2026 08:51:01 PM
- ANI Pharmaceuticals (ANIP) shares jump after earnings beat and higher outlook • IH Market News • 05/08/2026 01:45:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2026 10:58:11 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2026 10:56:34 AM
- ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance • GlobeNewswire Inc. • 05/08/2026 10:50:00 AM
- ANI Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 8, 2026, at 8:00 a.m. ET • GlobeNewswire Inc. • 04/24/2026 10:50:00 AM
- ANI Pharmaceuticals Announces the FDA Approval and Launch of Pimozide Tablets with 180 Day CGT Exclusivity • GlobeNewswire Inc. • 04/20/2026 10:50:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/13/2026 08:40:36 PM
- ANI Pharmaceuticals rolls out generic carbamazepine extended-release capsules • IH Market News • 04/13/2026 03:12:39 PM
- ANI Pharmaceuticals Announces the Launch of Carbamazepine Extended-Release Capsules • GlobeNewswire Inc. • 04/13/2026 10:50:00 AM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/09/2026 08:14:24 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/09/2026 08:13:29 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/09/2026 08:12:05 PM
- ANI Pharmaceuticals Announces FDA Approval and Launch of Isosorbide Mononitrate Tablet • GlobeNewswire Inc. • 04/08/2026 10:50:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 08:21:22 PM
- ANI Pharmaceuticals Announces Publication of NEW DAY Clinical Trial Results in Ophthalmology • GlobeNewswire Inc. • 04/07/2026 10:50:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/13/2026 09:28:48 PM
